Based on the results showing increased IL-17 protein expression in canine mammary tumors compared to healthy tissue, we believe that IL-17 supports tumor growth and may exert more proangiogenic effects than the immunomodulatory activity in canine mammary tumors. The gene discussed is IL17A; the disease is neoplasm.